ISRCTN93410321已完成未知
Personalised nutrition in non-alcoholic fatty liver disease (NAFLD): Feasibility of a nutrigenomic therapeutic approach
ewcastle upon Tyne Hospitals NHS Foundation Trust0 个研究点目标入组 49 人开始时间: 2020年2月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 49
研究概览
简要总结
2021 Protocol article in http://dx.doi.org/10.1136/bmjopen-2020-045922 (added 15/08/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18-80 years
- •2. NAFLD confirmed on liver biopsy or by clinical diagnosis with imaging evidence of steatosis
- •3. Weekly alcohol consumption <14 units (women) or <21 units (men) in last 24 months
- •4. Weight stable (+/-5%) for 3 months
- •5. Capacity to provide informed consent.
- •6. Ability to write and converse in English without assistance of an interpreter
排除标准
- •1. Liver neoplasm/cancer within 5 years (except squamous cell carcinoma)
- •2. Evidence of co-existent liver disease/presence of secondary causes of NAFLD (except Gilbert's syndrome).
- •3. Decompensated NASH-cirrhosis (Child Pugh >5-6)
- •4. Uncontrolled psychiatric disorder (e.g. acute psychosis)
- •5. Uncontrolled medical condition (e.g. HbA1c >80mmol/l or acute coronary event or stroke within 12 months)
- •6. Active eating disorder
- •7. Active substance misuse
- •8. Prescribed other dietary regimens+/-food intolerances or food allergies
- •9. Mediterranean diet point score (MEDAS) >8 (high MD consumption)
- •10. Previous weight loss surgery
- •11. Taking anti-obesity medications+/-engaged in structured, multi-component weight management interventions (specialist, community or commercial providers)
- •12. Insulin use
- •13. Pregnancy/ lactation
研究者
相似试验
已完成
Unknown
Personalized diets for treatment of fatty liver and central obesityOverweight, non-alcoholic fatty liver diseaseDigestive SystemISRCTN86495943Academy of Finland49
已完成
不适用
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and PrebioticsNonalcoholic Fatty Liver DiseaseNCT00870012Chinese University of Hong Kong20
已完成
不适用
Research on nutritional therapy for non-alcoholic fatty liver disease.non-alcoholic fatty liver diseaseJPRN-UMIN000022730Molecular Gastroentroerology and Hepatology, Kyoto Prefectural University15
招募中
不适用
Establishment of NAFLD Cohort and Development of Fibrosis MarkersFibrosis of LiverNCT02206841Seoul National University Boramae Hospital1,000
Unknown
不适用
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical ActivityNon Alcoholic Fatty Liver DiseaseNCT04442620University of the Balearic Islands150